...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats
【24h】

Protective Effects of Huang-Lian-Jie-Du-Tang against Polymicrobial Sepsis Induced by Cecal Ligation and Puncture in Rats

机译:黄连 - 德 - 唐对大鼠盲肠结扎和穿刺诱导多元细胞败血症的保护作用

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Huang-Lian-Jie-Du-Tang (HLJDT) is a traditional formula that has long been used for treatment of inflammatory diseases in Traditional Chinese Medicine. In this study, we examined its protective effect against sepsis in an experimental septic model induced by cecal ligation and puncture (CLP) in rats. The results demonstrated that prophylactic administration of HLJDT protected rats from CLP-induced lethality and ameliorated CLP-induced liver and lung injury. HLJDT treatment suppressed the production of proinflammatory cytokines, including TNF-a, IL-1, IL-6, and IL-17A, indicating HLJDT could limit excessive inflammatory responses in septic condition. In addition, HLJDT facilitated bacterial clearance by increasing phagocytic activities of peritoneal macrophages. Furthermore, HLJDT treatment reversed CLP-induced suppression of IFN-y expression and blocked CLP-induced increase in IL-4 expression in spleens of rats at 24 h after CLP, indicating that HLJDT could reverse the shift from Thl to Th2 response and promote Thl/Th2 balance toward Thl predominance in septic rats. Moreover, HLJDT also inhibited the expression of IL-17A and ROR-yt in spleens of septic rats, indicating HLJDT is able to inhibit Thl7 activation in septic condition. In conclusion, the present study demonstrated the protective effects of HLJDT against sepsis and highlighted the potential of HLJDT as a medication for septic patients.
机译:Huang-Lian-du-Tang(HLJDT)是一种传统的配方,长期以来一直用于治疗中药炎症疾病。在这项研究中,我们在大鼠盲肠结扎和穿刺(CLP)诱导的实验性化脓模型中对脓毒症进行了保护作用。结果表明,来自CLP诱导的致死性和改善的CLP诱导的肝脏和肺损伤的HLJDT保护大鼠的预防施用。 HLJDT治疗抑制了促炎细胞因子的生产,包括TNF-A,IL-1,IL-6和IL-17A,表明HLJDT可能限制脓毒症条件下过度炎症反应。此外,通过增加腹膜巨噬细胞的吞噬活性,HLJDT促进细菌清除。此外,HLJDT治疗反转CLP诱导的IFN-Y表达抑制,并在CLP后24小时抑制了IFN-Y表达的抑制,并阻断了在大鼠脾脏中IL-4表达的增加,表明HLJDT可以从TH1逆转到TH2响应并促进THL / Th2在脓毒症大鼠中朝向Th1的平衡。此外,HLJDT还抑制了渗透物质脾脏的IL-17a和ROR-YT的表达,表明HLJDT能够在脓盐条件下抑制TH17活化。总之,本研究表明HLJDT对败血症的保护作用,并强调了HLJDT作为脓毒症患者药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号